CAS: 1315330-17-6
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | 3-(6,7-Dimethoxyquinazolin-4-yloxy)-N-(4-((4-ethylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-4-methylbenzamide REF: 3D-QCC33017CAS: 1315330-17-6 | Min. 95% | A consultar | Mié 12 Feb 25 |
 | TL02-59 REF: TM-T13186CAS: 1315330-17-6 | 95.63% | 69,00 €~903,00 € | Mié 05 Mar 25 |
3-(6,7-Dimethoxyquinazolin-4-yloxy)-N-(4-((4-ethylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-4-methylbenzamide
CAS:1315330-17-6
3-(6,7-Dimethoxyquinazolin-4-yloxy)-N-(4-((4-ethylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-4-methylbenzamide is a potent inhibitor of the human TRPV2 ion channel. It has been shown …
Fórmula:
C32H34F3N5O4
Pureza:
Min. 95%
Peso molecular:
609.6 g/mol
Ref: 3D-QCC33017
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Miércoles 12 de Febrero de 2025
TL02-59
CAS:1315330-17-6
TL02-59: Fgr inhibitor (IC50=0.03nM), also targets Lyn (0.1nM), Hck (160nM), halts acute myelogenous leukemia growth.
Fórmula:
C32H34F3N5O4
Pureza:
95.63%
Forma y color:
Solid
Peso molecular:
609.64
- Inhibidores
- Apoptosis
- Tirosina quinasa / adaptadores
- Hck
- Ver más categorías
- Src
Ref: TM-T13186
| 1mg | 69,00 € | ||
| 5mg | 130,00 € | ||
| 10mg | 205,00 € | ||
| 25mg | 346,00 € | ||
| 50mg | 493,00 € | ||
| 100mg | 671,00 € | ||
| 200mg | 903,00 € | ||
| 1mL*10mM (DMSO) | 169,00 € |
Entrega estimada en Estados Unidos, el Miércoles 5 de Marzo de 2025
